Nyra Medical, Inc.

DECATUR, GA · Founded 2018 · CIK 0001955347 · Medtech · Private

CARLEN, a single-leaflet mitral valve repair device for transcatheter edge-to-edge repair (TEER)

nyramedical.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$12M
1 Form D · Nov 2022
47 months since last filing
Contracts
—
No federal contracts on record
Patents
4
1 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,999,977
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1483CuePath Innovation Inc.—$59K
1484Pathway Labs, Inc.—$3.8M
1485OBSIDIO, INC.——
1486Nyra Medical, Inc.—$12M
1487Vasc-Alert LLC—$163K
1488GENECAPTURE, INC.—$2.5M
1489Decision Sciences Medical Co LLC—$12M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Lisa HeineDirector
  • Sai Muralidhar PadalaDirector · Executive Officer
  • Gowri RamanDirector
  • Eric SarinDirector
  • Amrinder SinghDirector

Patents

USPTO · 1 granted of 4
  • Systems, Devices, And Methods For Reducing Heart Valve Regurgitationapplication
  • Systems, Devices, And Methods For Reducing Heart Valve Regurgitationgranted
  • Systems, Devices, And Methods For Reducing Heart Valve Regurgitationapplication
  • Systems, Devices, And Methods For Reducing Heart Valve Regurgitationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.